Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-0.76 Insider Own0.60% Shs Outstand1.09B Perf Week-1.32%
Market Cap13.94B Forward P/E4.86 EPS next Y2.62 Insider Trans-2.62% Shs Float1.08B Perf Month26.36%
Income-825.00M PEG- EPS next Q0.54 Inst Own50.40% Short Float1.59% Perf Quarter16.12%
Sales16.95B P/S0.82 EPS this Y59.40% Inst Trans-7.32% Short Ratio1.00 Perf Half Y24.27%
Book/sh12.38 P/B1.03 EPS next Y4.79% ROA-1.40% Target Price10.89 Perf Year33.79%
Cash/sh1.65 P/C7.72 EPS next 5Y3.20% ROE-6.00% 52W Range6.07 - 13.76 Perf YTD30.10%
Dividend- P/FCF33.74 EPS past 5Y-17.70% ROI-0.40% 52W High-7.34% Beta1.65
Dividend %- Quick Ratio0.70 Sales past 5Y-3.60% Gross Margin45.80% 52W Low110.05% ATR0.55
Employees40039 Current Ratio1.00 Sales Q/Q5.00% Oper. Margin-2.30% RSI (14)64.56 Volatility3.76% 4.81%
OptionableYes Debt/Eq1.93 EPS Q/Q165.40% Profit Margin-4.90% Rel Volume0.39 Prev Close12.88
ShortableYes LT Debt/Eq1.81 EarningsMay 07 BMO Payout- Avg Volume17.16M Price12.75
Recom2.90 SMA206.75% SMA5020.95% SMA20033.97% Volume6,769,445 Change-1.01%
Jun-01-20Upgrade SunTrust Hold → Buy
Apr-24-20Resumed Citigroup Neutral $10
Apr-06-20Upgrade UBS Neutral → Buy $14 → $12
Feb-24-20Downgrade Edward Jones Hold → Sell
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jun-04-20 03:22PM  
Jun-02-20 08:00AM  
May-31-20 07:40AM  
06:35AM  
May-30-20 06:30AM  
May-29-20 11:50AM  
06:40AM  
May-27-20 05:51AM  
May-26-20 08:00AM  
May-25-20 02:00AM  
May-22-20 05:59AM  
02:00AM  
May-21-20 03:38PM  
05:51AM  
May-19-20 03:18PM  
May-18-20 07:00AM  
May-16-20 11:48AM  
May-14-20 02:43PM  
02:37PM  
08:00AM  
May-13-20 11:50AM  
May-09-20 01:31PM  
May-08-20 09:56AM  
May-07-20 07:03PM  
05:33PM  
04:11PM  
02:52PM  
02:15PM  
01:24PM  
09:07AM  
08:39AM  
08:04AM  
07:10AM  
07:00AM  
05:00AM  
May-05-20 04:50PM  
06:45AM  
01:02AM  
May-04-20 11:52AM  
08:00AM  
May-01-20 04:55PM  
08:00AM  
Apr-30-20 10:22AM  
Apr-29-20 06:06AM  
Apr-28-20 05:50PM  
Apr-27-20 08:00AM  
Apr-16-20 06:27PM  
Apr-07-20 05:50PM  
05:46PM  
09:46AM  
09:45AM  
07:30AM  
Apr-06-20 11:37AM  
Apr-05-20 10:22AM  
Apr-03-20 02:39AM  
Mar-31-20 01:27PM  
01:09PM  
12:32PM  
Mar-27-20 06:45PM  
01:20PM  
Mar-26-20 05:45PM  
Mar-24-20 05:16PM  
09:57AM  
Mar-22-20 10:13AM  
Mar-21-20 11:03AM  
10:23AM  
Mar-20-20 05:45PM  
10:44AM  
10:24AM  
08:56AM  
08:00AM  
07:47AM  
Mar-19-20 08:23PM  
Mar-17-20 02:03PM  
Mar-16-20 08:00AM  
Mar-12-20 03:30AM  
Mar-10-20 02:52PM  
Mar-03-20 04:43PM  
09:53AM  
Feb-28-20 10:07AM  
09:07AM  
Feb-27-20 06:11PM  
01:12PM  
Feb-26-20 01:03PM  
Feb-25-20 04:27PM  
10:14AM  
08:23AM  
Feb-24-20 12:41PM  
12:25PM  
08:00AM  
Feb-21-20 07:37PM  
09:16AM  
Feb-20-20 07:06AM  
Feb-14-20 07:10AM  
Feb-13-20 02:42PM  
01:31PM  
08:53AM  
Feb-12-20 05:19PM  
04:50PM  
04:14PM  
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Griffin Deborah AChief Accounting OfficerMar 17Sale7.169446,7620Mar 19 08:09 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 17Sale7.162,35916,8992,974Mar 19 07:38 AM
O'Grady Brendan P.EVP, North America CommercialMar 17Sale7.164703,36714,868Mar 19 07:37 AM
Nazzi GianfrancoEVP, International MarketsMar 17Sale7.173452,47419,844Mar 19 07:36 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 17Sale7.165143,68245,561Mar 19 07:33 AM
Daniell RichardExec. VP, European CommercialMar 17Sale7.176164,41810,400Mar 19 07:31 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale11.234,80753,9800Mar 05 08:16 AM
O'Grady Brendan P.EVP, North America CommercialMar 03Sale11.374635,26214,159Mar 05 08:13 AM
Nazzi GianfrancoEVP, International MarketsMar 03Sale11.775486,44819,315Mar 05 08:11 AM
Daniell RichardExec. VP, European CommercialMar 03Sale11.7799111,6609,719Mar 05 08:07 AM
Griffin Deborah AChief Accounting OfficerMar 03Sale11.371,16613,2530Mar 04 06:39 AM
Griffin Deborah AChief Accounting OfficerMar 02Sale11.602,94134,1120Mar 04 06:39 AM
Drape EricExecutive VP Global OperationsFeb 19Sale12.518,000100,08021,494Feb 20 07:17 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale12.1411,472139,29545,061Feb 18 07:23 AM
Drape EricExecutive VP Global OperationsFeb 14Sale12.148,14098,78529,494Feb 18 07:22 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale12.1417,016206,6122,974Feb 18 07:26 AM
Sabag MarkSee "Remarks" belowFeb 13Sale13.0372,131939,7600Feb 18 07:25 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 10Sale12.2412,538153,4712,974Feb 11 07:06 AM
O'Grady Brendan P.EVP, North America CommercialFeb 10Sale12.274,79958,88413,456Feb 11 07:02 AM
Nazzi GianfrancoEVP, Growth Markets CommercialFeb 10Sale12.244,15550,86418,464Feb 11 07:01 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 10Sale12.275,54468,02533,330Feb 11 06:57 AM
Drape EricExecutive VP Global OperationsFeb 10Sale12.243,14438,48820,618Feb 11 06:56 AM
Dethlefs SvenEVP Global Marketing&PortfolioFeb 10Sale12.275,66969,55918,061Feb 11 06:53 AM
Daniell RichardExec. VP, European CommercialFeb 10Sale12.246,19975,8868,612Feb 11 06:52 AM
Fridriksdottir HafrunExecutive VP, Global R&DDec 31Sale9.922,45924,39622,754Jan 02 06:08 AM
Fridriksdottir HafrunExecutive VP, Global R&DDec 02Sale10.494,31045,21420,573Dec 03 06:32 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale8.832422,13815,898Nov 06 06:46 AM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale7.829627,52310,678Sep 20 07:19 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale7.834943,8692,135Sep 20 07:19 AM
McClellan Michael JamesEVP, Chief Financial OfficerSep 18Sale7.831,40611,01115,445Sep 20 07:17 AM
Griffin Deborah AChief Accounting OfficerSep 18Sale7.832,37618,6070Sep 20 07:12 AM
Daniell RichardExec. VP, European CommercialSep 18Sale7.821,1769,1971,676Sep 20 07:10 AM
Daniell RichardExec. VP, European CommercialSep 09Sale7.163332,384363Sep 11 06:58 AM